TAK-881

Trials studying TAK-881

• phase3A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseasesactive not recruitingn=53
• phase3A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseasescompletedn=65
• phase3A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)recruitingn=59
• phase1A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy Adultscompletedn=64
• phase1A Study of TAK-881 and HyQvia in Healthy Adultscompletedn=30
• —Expanded Access to TAK-881 for Children and Teenagers With Primary Immunodeficiency Diseases in the USAavailable
• phase1A Study of TAK-881 in Healthy Adultscompletedn=24